Company Filing History:
2 out of 164 
2 out of 38 
Years Active: 2012-2013
Title: Aung Naing Lwin: Innovator in GLP-1 Receptor Agonist Bioassays
Introduction
Aung Naing Lwin is a notable inventor based in Carlsbad, California. He has made significant contributions to the field of biochemistry, particularly in the development of bioassays for GLP-1 receptor agonists. With a total of two patents to his name, Lwin's work is instrumental in advancing medical research and therapeutic applications.
Latest Patents
Lwin's latest patents focus on GLP-1 receptor agonist bioassays. These patents provide cell-based bioassays for measuring the activity of test compounds that act as GLP-1 receptor agonists. The bioassays are designed to quantitatively determine the cAMP generated in samples containing these compounds, such as exenatide. The assays utilize 6-23 (clone 6) cells that have GLP-1 receptors, allowing for a correlation between the amount of cAMP generated and the agonist activity of the compounds. Suitable methods for these bioassays include enzyme-linked immunosorbent assays and homogeneous time-resolved fluorescence assays.
Career Highlights
Throughout his career, Aung Naing Lwin has worked with prominent companies in the pharmaceutical industry. He has been associated with Amylin Pharmaceuticals, Inc. and AstraZeneca Pharmaceuticals LP. His experience in these organizations has contributed